Conversely, while nearly all cases of extracranial rhabdoid tumors harbored mutations of SMARCB1, SMARCA4 mutations were only observed in approximately 0.5%–2% atypical teratoid/rhabdoid tumors.30, 31. This evidence concerns the gene SMARCB1 and rhabdoid tumor.